3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
121
Carcinoma, Renal Cell
60
Neoplasms
43
Liver Neoplasms
42
Neoplasm Metastasis
23
Carcinoma, Non-Small-Cell Lung
21
Leukemia, Myeloid, Acute
20
Melanoma
18
Kidney Neoplasms
16
Breast Neoplasms
16
Brain Neoplasms
13
Pancreatic Neoplasms
12
Sarcoma
11
Prostatic Neoplasms
10
Glioblastoma
10
Lung Neoplasms
9
Thyroid Neoplasms
8
Recurrence
8
Rectal Neoplasms
8
Colorectal Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Colonic Neoplasms
7
Stomach Neoplasms
6
Ovarian Neoplasms
6
Multiple Myeloma
6
Leukemia
6
Gliosarcoma
6
Carcinoma
6
Unspecified Adult Solid Tumor, Protocol Specific
5
Urinary Bladder Neoplasms
4
Interventions
Cisplatin
38
Fluorouracil
37
Radiotherapy
33
Oxaliplatin
23
Paclitaxel
20
Irinotecan
18
Leucovorin
17
Docetaxel
17
Capecitabine
10
Neoadjuvant Therapy
9
Surgical Procedures, Operative
8
Cetuximab
8
Chemotherapy, Adjuvant
7
Radiation
6
Carboplatin
6
Immunohistochemistry
5
Erlotinib Hydrochloride
5
Biopsy
5
Magnetic Resonance Spectroscopy
4
Gene Expression Profiling
4
Folfox protocol
4
Epirubicin
4
Drug Therapy
4
pembrolizumab
3
Trastuzumab
3
Microarray Analysis
3
Gefitinib
3
Fluorodeoxyglucose F18
3
Endoscopy, Digestive System
3
ixabepilone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Adenocarcinoma Of Esophagus
×
Sorafenib
×
Clear all
NCT01158287
2014-12-31
Sorafenib. ICORG 06-41, V4
Cancer Trials Ireland
Phase 2
Completed
54 enrolled